arrow_back Trending Legislation
Share share

Faster access to new drugs and therapies in Poland

The act changes the rules for introducing new medical technologies into the healthcare system. Patients can gain faster access to innovative drugs because Poland will use European clinical assessments instead of requiring its own.
Key points
New drugs and therapies will reach patients faster thanks to simplified procedures.
Poland will use EU reports evaluating drug effectiveness.
Manufacturers do not need to repeat studies if already conducted at EU level.
Changes mainly concern oncology and rare diseases.
article Official text account_balance Process page notifications_active Track this Bill
60%
VOTING RESULTS
2025-07-25
For 259
Against 4
Abstain 167
Full voting results open_in_new
gavel
Status:
Became Law
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Rządowy projekt ustawy o zmianie ustawy o refundacji leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych oraz ustawy o świadczeniach opieki zdrowotnej finansowanych ze środków publicznych.
Print number: PROJEKT USTAWY 1429
Process start date: 2025-07-08
Voting date: 2025-07-25
Voting no: 77
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: kimi-k2.5
Source data: api.sejm.gov.pl
AI work logs for this document launch
Summary & Status

Key Questions about Faster access to new drugs and therapies in Poland

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is PROJEKT USTAWY 1429.

When did the legislative process begin?

The process officially started on 2025-07-08.

What are the main provisions?

Key points include:

  • New drugs and therapies will reach patients faster thanks to simplified procedures.
  • Poland will use EU reports evaluating drug effectiveness.
  • Manufacturers do not need to repeat studies if already conducted at EU level.
  • Changes mainly concern oncology and rare diseases.

What is the specific legal status?

The current status is Became Law.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Where is the official voting record?

The official roll call vote is recorded at: voting record

What is the latest detailed status?

The latest detailed status is: Uchwalono

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-09-07.

Analysis and Potential Impact of PROJEKT USTAWY 1429

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health